VanEck Pharmaceutical ETF Rating $85.99 -2.04 (-2.32%) Closing price 04:00 PM EasternExtended Trading$85.98 -0.01 (-0.01%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.59Holdings in PPH have an aggregate rating of Moderate Buy based on 280 analyst ratings issued in the past year covering 22 companies (92.1% of the portfolio).PPH Aggregate Price Target$85.99High Prediction$85.99Average Prediction$85.99Low Prediction$85.99Holdings in PPH have an aggregate price target of $85.99 and a range of $85.99 to $85.99 covering 22 companies (92.1% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.80%LLYEli Lilly and Company$713.87-3.8%4.9985 of 5 stars2.67$939.61 31.6%24Trending News11.57%JNJJohnson & Johnson$177.71+0.6%4.7253 of 5 stars2.67$181.40 2.1%21Trending NewsAnalyst Upgrade6.06%MRKMerck & Co., Inc.$77.70-2.5%4.9993 of 5 stars2.33$106.41 37.0%21Positive News5.95%NVONovo Nordisk A/S$56.07-4.5%4.1065 of 5 stars2.37$81.00 44.5%19Trending NewsGap Down5.22%ABBVAbbVie$218.23-0.8%4.8081 of 5 stars2.93$223.45 2.4%27Trending NewsAnalyst ForecastAnalyst Revision4.94%AZNAstraZeneca$73.53-2.4%3.165 of 5 stars2.75$86.00 17.0%4Positive News4.54%MCKMcKesson$737.65-3.0%4.8422 of 5 stars2.86$826.91 12.1%14Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume4.49%GSKGSK$39.57-1.5%1.784 of 5 stars1.86$37.38 -5.5%7Dividend Cut4.47%PFEPfizer$23.61-2.0%4.9912 of 5 stars2.39$28.12 19.1%18Trending NewsOptions Volume4.34%SNYSanofi$45.07-2.9%3.9911 of 5 stars3.11$62.67 39.0%94.22%BMYBristol Myers Squibb$43.45-1.6%4.8977 of 5 stars2.24$56.38 29.7%21Positive News4.08%ZTSZoetis$141.03-0.5%4.8212 of 5 stars2.56$200.88 42.4%9Positive News3.88%CORCencora$299.21-3.0%4.7896 of 5 stars2.75$311.25 4.0%12Positive NewsInsider Trade3.43%HLNHaleon$8.74-1.4%4.2664 of 5 stars2.70$12.33 41.0%10Positive News2.88%TAKTakeda Pharmaceutical$14.68-1.9%2.3904 of 5 stars2.0021.87%TEVATeva Pharmaceutical Industries$18.43-4.4%2.6377 of 5 stars3.25$25.14 36.4%8Trending NewsAnalyst Forecast0.72%VTRSViatris$9.49-2.3%1.8995 of 5 stars1.80$10.40 9.6%5News CoveragePositive News0.55%JAZZJazz Pharmaceuticals$127.80-1.4%4.3442 of 5 stars2.88$178.93 40.0%16Positive NewsAnalyst Forecast0.43%ELANElanco Animal Health$18.93+1.0%2.5033 of 5 stars2.78$18.33 -3.1%9News CoverageAnalyst Forecast0.31%AXSMAxsome Therapeutics$116.01-2.3%4.8205 of 5 stars3.13$177.86 53.3%15Insider Trade0.19%OGNOrganon & Co.$10.13-2.7%4.4755 of 5 stars2.80$17.33 71.1%5Positive News0.17%PRGOPerrigo$20.79-2.8%4.7789 of 5 stars2.50$34.00 63.6%4 This page (NASDAQ:PPH) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPH Stock Alerts